|
J Biol Chem, Vol. 273, Issue 20, 12332-12340, May 15, 1998
Evidence from Transgenic Mice That Interferon- May Be Involved
in the Onset of Diabetes Mellitus
Mireia
Pelegrin,
Jean Christophe
Devedjian,
Cristina
Costa,
Joana
Visa,
Gemma
Solanes,
Anna
Pujol,
Guillermina
Asins,
Alfons
Valera, and
Fatima
Bosch
From the Departament de Bioquímica i Biologia Molecular,
Facultat de Veterinària, Universitat Autònoma de Barcelona,
08193-Bellaterra, Spain
A number of cytokines have been shown to alter
the function of pancreatic -cells and thus might be involved in the
development of type 1 diabetes. Interferon- (IFN- ) expression is
induced in epithelial cells by several viruses, and it has been
detected in islets of type 1 diabetic patients. Here we show that
treatment of isolated mouse islets with this cytokine was able to alter insulin secretion in vitro. To study whether IFN- alters
-cell function in vivo and leads to diabetes, we have
developed transgenic mice (C57BL6/SJL) expressing IFN- in -cells.
These mice showed functional alterations in islets and impaired
glucose-stimulated insulin secretion. Transgenic animals presented mild
hyperglycemia, hypoinsulinemia, hypertriglyceridemia, and altered
glucose tolerance test, all features of a prediabetic state. However,
they developed overt diabetes, with lymphocytic infiltration of the
islets, when treated with low doses of streptozotocin, which did not
induce diabetes in control mice. In addition, about 9% of the
transgenic mice obtained from the N3 back-cross to outbred albino CD-1
mice spontaneously developed severe hyperglycemia and hypoinsulinemia and showed mononuclear infiltration of the islets. These results suggest that IFN- may be involved in the onset of type 1 diabetes when combined with either an additional factor or a susceptible genetic
background.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman
Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation
Endocr. Rev.,
August 1, 2008;
29(5):
603 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Dogusan, M. Garcia, D. Flamez, L. Alexopoulou, M. Goldman, C. Gysemans, C. Mathieu, C. Libert, D. L. Eizirik, and J. Rasschaert
Double-Stranded RNA Induces Pancreatic {beta}-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways
Diabetes,
May 1, 2008;
57(5):
1236 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Casellas, A. Salavert, J. Agudo, E. Ayuso, V. Jimenez, M. Moya, S. Munoz, S. Franckhauser, and F. Bosch
Expression of IGF-I in Pancreatic Islets Prevents Lymphocytic Infiltration and Protects Mice From Type 1 Diabetes
Diabetes,
December 1, 2006;
55(12):
3246 - 3255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rasschaert, L. Ladriere, M. Urbain, Z. Dogusan, B. Katabua, S. Sato, S. Akira, C. Gysemans, C. Mathieu, and D. L. Eizirik
Toll-like Receptor 3 and STAT-1 Contribute to Double-stranded RNA+ Interferon-{gamma}-induced Apoptosis in Primary Pancreatic {beta}-Cells
J. Biol. Chem.,
October 7, 2005;
280(40):
33984 - 33991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Vassileva, S.-C. Chen, M. Zeng, S. Abbondanzo, K. Jensen, D. Gorman, B. M. Baroudy, Y. Jiang, N. Murgolo, and S. A. Lira
Expression of a Novel Murine Type I IFN in the Pancreatic Islets Induces Diabetes in Mice
J. Immunol.,
June 1, 2003;
170(11):
5748 - 5755.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|